Remission of Grave's disease after oral anti-thyroid drug treatment

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 11, 2009, Pages 690-693

  Ishtiaq, Osama ^a   Waseem, Sabiha ^a   Haque, M Naeemul ^a   Islam, Najmul ^a   Jabbar, Abdul ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Free t4 level; Graves disease; Oral anti thyroid medication; Remission

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; MICROSOME ANTIBODY; PERTECHNETIC ACID TC 99M; THIONAMIDE DERIVATIVE; THYROGLOBULIN ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHI SQUARE TEST; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DRUG DOSE TITRATION; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RELAPSE; REMISSION; STUDENT T TEST; SYMPTOMATOLOGY; THYROID SCINTISCANNING; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; FEMALE; GRAVES DISEASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; REMISSION INDUCTION;

EID: 73349109481     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2000; 85:1038-42.
2. Wille T, Müller B, Noth D, Bürgi U, Diem P. [Long-term follow up after antithyroid drug treatment in Graves' disease]. Praxis (Bern 1994) 2006; 95:1121-7. German.
3. Read CH Jr, Tansey MJ Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 2004; 89:4229-33. Comment in: p. 4227-8.
4. Abraham-Nordling M, Torring O, Hamberger B, Lundell G, Tallstedt L, Calissendorff J, et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid 2005; 15:1279-86.
5. Abraham P, Avenell A, Park CM, Watson WA, Bevan JS. A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol 2005; 153:489-98.
6. Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Fassbinder J, et al. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the treatment of hyperthyroidism with antithyroid drugs. Clin Endocrinol (Oxf) 1998; 49:451-7.
7. Glinoer D, de Nayer P, Bex M. Belgian collaborative study group on Graves ' disease. Effects of I-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. Eur J Endocrinol 2001; 144:475-83.
8. Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism? Eur J Endocrinol 2006; 155:783-6.
9. Werner S. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977; 44:203-4.
10. Alfadda A, Malabu UH, El-Desauki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, et al. Treatment of Graves' hyperthyroidism - prognostic factors for outcome. Saudi Med J 2007; 28:225-30.
11. Nedrebo BG, Holm PI, Uhlving S, Sorheim JI, Skeie S, Eide E, et al. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. Eur J Endocrinol 2002; 147:583-9.
12. Crivellaro C, Oberhofer R, Leimgruber K, Amor H. Graves' disease. Clinical features and treatment results (German). Acta Med Austriaca 2001; 28:47-51.
13. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. J Clin Endocrinol Metab 1996; 81:2986-93.
14. Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 2004; 36:92-6.
15. Chiou SC, Houng HS, Li KL, Ghang TC, Lo SK, Sun RH, et al. Outcome of Graves' thyrotoxicosis after antithyroid drug treatment. Changgeng Yi Xue Za Zbi 1995; 18:305-14.
16. Wang PW, Liu RT, Tung SC, Chien WY, Lu YC, Chen CH, et al. Outcome of Grave's disease after antithyroid drug treatment in Taiwan. J Formos Med Assoc 1998; 97:619-25.
17. Soveid M, Shaabani A, Ghaedi GH, Jafari SM, Omrani GH. Prognostic factors in the relapse of Graves' disease following treatment with antithyroid drugs. Iran J Med Sci 2003; 28:106-10.